April 25, 2008 - Pfizer has entered into a collaboration agreement with four major research universities – University of California, Santa Barbara (UCSB); Caltech; the Massachusetts Institute of Technology; and University of Massachusetts – and Entelos, a physiological modeling company, to re-examine the regulatory mechanisms of human energy metabolism.
Pfizer is funding the three-year and $14 million Insulin Resistance Pathway (IRP) Project to look at insulin signaling in adipose (fat) cells to increase understanding of diabetes and obesity, inextricably linked conditions that affect 7 percent of the U.S. population... Pfizer's Press Release -
Blog Archive
-
▼
2008
(233)
-
▼
May
(27)
- Pipex Pharmaceuticals : Oral Flupirtine Patent Est...
- Daiichi Sankyo : AZOR Reduces Blood Pressure in Di...
- DiaMedica : pre-IND FDA Guidance on DM-71
- ALR Technologies : ECHO of Alabama Employer Coalit...
- AtheroGenics : ARISE Trial Results Published in Th...
- Daiichi Sankyo : Welchol, Combined With Metformin ...
- DiaMedica : Enrollment in Phase II Clinical Trial ...
- Allon : potential of AL-309 as a new neuropathy tr...
- Entelos : Agreement with Lilly
- FivePrime and Pfizer : Diabetes Collaboration
- Diasome Pharmaceuticals : at the 68th Annual Ameri...
- Phenomix : PHX1149 Phase 2b Clinical Trial Results...
- Aradigm : Data Showing No Occurrence of Primary Lu...
- MicroIslet : Collaboration With DiaKine Intended T...
- CytRx : Discovery of Novel Compounds that Amplify ...
- RegeneRx : Ophthalmic Patent in Hong Kong
- Elixir Pharmaceuticals : Issuance of SIRT Patent C...
- OXiGENE : Active Metabolite of ZYBRESTAT Improves...
- Incyte : Positive Clinical Progress
- Merck's JANUMET (sitagliptin/metformin HCl) Recomm...
- Pfizer : Research Consortium to Expand Understandi...
- NOVAGALI : First Patient in U.S. Phase I Clinical ...
- Solianis Monitoring : Non-Invasive Glucose Monitoring
- Nektar Terminates All Negotiations With Potential ...
- CureDM : Diabetes Therapy Major Development Achieved
- Biocon Limited : Phase IIa Clinical Trials for IN105
- Toumaz Technology and Consortium Partners : Major ...
-
▼
May
(27)